Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
KPTI•Inducement grants reported
- Karyopharm Therapeutics reports inducement grants under Nasdaq Listing Rule 5635(c)(4).
Source text: ID:nPn87BM6Ka
KPTI•KPTI•KPTI•Source text: ID:nPn87BM6Ka
